Constitutive endocytic cycle of the CB1 cannabinoid receptor

被引:186
|
作者
Leterrier, C
Bonnard, D
Carrel, D
Rossier, J
Lenkei, Z
机构
[1] Ecole Super Phys & Chim Ind Ville Paris, Lab Neurobiol & Diversite Cellulaire, CNRS, UMR 7637, F-75231 Paris 05, France
[2] Univ Paris 06, INSERM, U288, F-75634 Paris 13, France
关键词
D O I
10.1074/jbc.M403990200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The CB1 cannabinoid receptor (CB1R) displays a significant level of ligand-independent (i.e. constitutive) activity, either when heterologously expressed in non-neuronal cells or in neurons where CB1Rs are endogenous. The present study investigates the consequences of constitutive activity on the intracellular trafficking of CB1R. When transfected in HEK-293 cells, CB1R is present at the plasma membrane, but a substantial proportion (similar to85%) of receptors is localized in intracellular vesicles. Detailed analysis of CB1-EGFP expressed in HEK-293 cells shows that the intracellular CB1R population is mostly of endocytic origin and that treatment with inverse agonist AM281 traps CB1R at the plasma membrane through a monensin-sensitive recycling pathway. Co-transfection with dominant positive or dominant negative mutants of the small GTPases Rab5 and Rab4, but not Rab11, profoundly modifies the steady-state and ligand-induced intracellular distribution of CB1R, indicating that constitutive endocytosis is Rab5-dependent, whereas constitutive recycling is mediated by Rab4. In conclusion, our results indicate that, due to its natural constitutive activity, CB1R permanently and constitutively cycles between plasma membrane and endosomes, leading to a predominantly intracellular localization at steady state.
引用
收藏
页码:36013 / 36021
页数:9
相关论文
共 50 条
  • [1] CONSTITUTIVE ACTIVITY AT THE CANNABINOID CB1 RECEPTOR AND BEHAVIORAL RESPONSES
    Hanlon, Katherine E.
    Vanderah, Todd W.
    [J]. METHODS IN ENZYMOLOGY, VOLUME 484: CONSTITUTIVE ACTIVITY IN RECEPTORS AND OTHER PROTEINS, PART A, 2010, 484 : 3 - 30
  • [2] Cannabinoid CB1 Receptor Antagonists
    Thomas, Brian F.
    [J]. DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
  • [3] The CB1 cannabinoid receptor in the brain
    Howlett, AC
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416
  • [4] CB1 cannabinoid receptor antagonists
    Barth, F
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 103 - 118
  • [5] CB1 cannabinoid receptor ligands
    Thakur, GA
    Nikas, SP
    Makriyannis, A
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (07) : 631 - 640
  • [6] The Cannabinoid CB1 Receptor in Schizophrenia
    Borgan, Faith
    Kokkinou, Michelle
    Howes, Oliver
    [J]. BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 646 - 659
  • [7] Voltage dependence of the cannabinoid CB1 receptor
    Goldberger, Esty
    Tauber, Merav
    Ben-Chaim, Yair
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Internalization and recycling of the CB1 cannabinoid receptor
    Hsieh, C
    Brown, S
    Derleth, C
    Mackie, K
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) : 493 - 501
  • [9] Allosteric Modulation of Cannabinoid CB1 Receptor
    Ross, Ruth A.
    Baillie, Gemma L.
    Pertwee, Roger G.
    [J]. FASEB JOURNAL, 2012, 26
  • [10] Allosteric modulation of the cannabinoid CB1 receptor
    Price, MR
    Baillie, GL
    Thomas, A
    Stevenson, LA
    Easson, M
    Goodwin, R
    McLean, A
    McIntosh, L
    Goodwin, G
    Walker, G
    Westwood, P
    Marrs, J
    Thomson, F
    Cowley, P
    Christopoulos, A
    Pertwee, RG
    Ross, RA
    [J]. MOLECULAR PHARMACOLOGY, 2005, 68 (05) : 1484 - 1495